Effect of subsequent therapies including checkpoint inhibitors on overall survival in a phase III randomized trial of tebentafusp in first-line metastatic uveal melanoma: Long-term follow-up Meeting Abstract


Authors: Orloff, M.; Watkins, C.; Carvajal, R. D.; Shoushtari, A. N.; Sacco, J. J.; Schlaak, M.; Gama, J.; Butler, M. O.
Abstract Title: Effect of subsequent therapies including checkpoint inhibitors on overall survival in a phase III randomized trial of tebentafusp in first-line metastatic uveal melanoma: Long-term follow-up
Meeting Title: ESMO Congress 2023
Journal Title: Annals of Oncology
Volume: 34
Issue: Suppl. 2
Meeting Dates: 2023 Oct 20-24
Meeting Location: Madrid, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2023-10-01
Start Page: S678
Language: English
ACCESSION: WOS:001087480201460
DOI: 10.1016/j.annonc.2023.09.2263
PROVIDER: wos
Notes: Meeting Abstract: 1129P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors